Literature DB >> 2658063

Clinical aspects of disseminated intravascular coagulation: a clinician's point of view.

W F Baker1.   

Abstract

DIC is a disorder of coagulation that is demonstrated to occur in many settings. In view of the fulminant nature of the disorder once it is fully activated, the potential for considerable morbidity and mortality, and the difficulty in treating this syndrome, the necessity for a thorough understanding of the disorder is clear. A high index of suspicion is absolutely essential; however, this requires a thorough knowledge of the medical and surgical disorders in which DIC is likely to occur. The presenting manifestations of DIC, the time course of development of the fulminant syndrome, and the specific complications of the disorder may be intrinsically related to the specific clinical characteristics of the underlying disease. Clinical evaluation of the patient must be comprehensive and consider not only the laboratory and clinical manifestations of DIC but the triggering illness. Without the ability to treat the underlying primary illness, controlling or abating the DIC may be difficult or impossible. This comprehensive review of the disease entities in which DIC is likely to occur and the associated clinical manifestations will, it is hoped, guide a more precise definition of the overall clinical picture that confronts the clinician when evaluating a patient with possible DIC.

Entities:  

Mesh:

Year:  1989        PMID: 2658063     DOI: 10.1055/s-2007-1002689

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  8 in total

1.  Activation of blood coagulation factor IX by gingipains R, arginine-specific cysteine proteinases from Porphyromonas gingivalis.

Authors:  T Imamura; S Tanase; T Hamamoto; J Potempa; J Travis
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

2.  Intracerebral hemorrhages, fibrinolysis, and prostate carcinoma.

Authors:  Johann S Braun; Rodger Novak; Michael Torzewski; Dietmar Soehngen
Journal:  J Neurol       Date:  2002-04       Impact factor: 4.849

3.  A 72-year-old woman with fever and diffuse intravascular coagulation.

Authors:  C F Allaart; G J den Ottolander; E Briët; R Bieger
Journal:  Ann Hematol       Date:  1992-09       Impact factor: 3.673

4.  Plasminogen activator inhibitor 1 promotes a poor prognosis in sepsis-induced disseminated intravascular coagulation.

Authors:  Seiji Madoiwa; Shin Nunomiya; Tomoko Ono; Yuichi Shintani; Tsukasa Ohmori; Jun Mimuro; Yoichi Sakata
Journal:  Int J Hematol       Date:  2006-12       Impact factor: 2.490

5.  Pancreatitis in acute hemolysis.

Authors:  W Druml; A N Laggner; K Lenz; G Grimm; B Schneeweiss
Journal:  Ann Hematol       Date:  1991-07       Impact factor: 3.673

6.  Coagulopathy in the prostate cancer patient: prevalence and clinical relevance.

Authors:  A S Adamson; J L Francis; R O Witherow; M E Snell
Journal:  Ann R Coll Surg Engl       Date:  1993-03       Impact factor: 1.891

Review 7.  Disseminated intravascular coagulation. Approach to treatment.

Authors:  R N Rubin; R W Colman
Journal:  Drugs       Date:  1992-12       Impact factor: 9.546

8.  Hyperlipidemia in acute hemolysis.

Authors:  W Druml; G Grimm; A N Laggner; B Schneeweiss; K Lenz
Journal:  Klin Wochenschr       Date:  1991-07-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.